Our Values

    • Safety & Quality

      Safety and quality are a priority for Renal Services. As a company, we manage all aspects of clinical care, quality control and infection provention at each of our clinics.
      The Care Quality Commission (CQC) regulates our services and we are proud of the fact that we consistently achieve 100% compliance with the CQC requirements, year after year.

    • Excellence in Patient Care

      All the Renal Services clinics provide dialysis patients with efficient, effective community-based services that offer:

      • Friendly, professional care to meet individual needs;
      • TVs, headphones and refreshments during treatment;
      • The latest medical technology for specialist therapies;
      • Clean, comfortable surroundings.

    • Independence

      As an independent company, Renal Services is not limited to one manufacturer’s products, we can provide the most appropriate dialysis machines and latest therapeutic options to suit each patient’s needs.
      By offering patients local dialysis units and holiday dialysis centres, we can also help them stay independent for longer.

    • Innovation

      Renal Services is at the forefront of innovation in the management of End Stage Renal Disease.
      We are an early adopter of new technologies in dialysis and vascular access and we support the development of new therapies, medical devices and drugs that improve patient outcomes.

Management Team

Meet our senior management team. They guide our company in it’s quest to achieve our values and goals for Renal Services’ patients and professional staff. All our management team members have considerable experience working within the dialysis industry in the UK, Europe and the US.

Stefano Ciampolini Chief Executive Officer and Co-Founder

Stefano Ciampolini is Adjunct Professor of Imperial College Business School in London and Entrepreneur-in-Residence at Imperial’s Enterprise Lab. Stefano started his career with his family’s group of companies, which included private clinics and diagnostic equipment manufacturing in Italy, France and the United States.

He joined Arthur Andersen in London in 1996, where he was a member of the healthcare corporate finance team. In 1999, Stefano founded NephroNet, a chain of independent dialysis centers in Italy, which was sold to Baxter in 2001. From 2001 to 2003 Stefano was a Managing Director of Baxter Renal Therapy Services. Since 2002 Stefano is Managing Partner at Healthcare Capital Partners (London), a private equity and corporate finance advisory boutique specialised in life sciences and healthcare ventures that he founded. As part of his activities, Stefano is a founder and board member of several healthcare ventures and private equity funds in Europe and the US.

Stefano earned an MBA from Imperial College Business School in 1994 and has a degree in Economics from Kingston University, London.

Kathy Lloyd Chief Operating Officer
 

Kathy has worked as a renal nurse specialist since 1994 and has been involved in the development and management of dialysis centres in the UK since 1998. She has managed renal services for Total Renal Care, Fresenius Medical Care and The London Clinic. As HR Project Manager at The London Clinic, Kathy was a key specialist in the delivery of the Human Resources strategy in enabling the organisation to become the employer of choice and in securing cost savings of over £1.5m in the first year of the project.

Kathy is responsible for the delivery and management of all clinical services provided by Renal Services, incorporating human resources management and business development. She provides nursing leadership to ensure the highest level of professional practice and patient care is met.

In addition to being a qualified RN, Kathy has an MBA, BSc Honours Degree in Health Services Management and she is PRINCE 2 qualified.

Dr Neluka Weerasooriya Head of Contracts - Quality & Regulatory

Neluka has over 20 years experience in renal nursing in both public and private sector hospitals. Her academic background is in chemistry and she has a PhD in Organic Chemistry. Neluka is responsible for the co-ordination and development of clinical governance activities and for the Renal Services’ registration programme with the Care Quality Commission. She is also responsible for monitoring standards of care in all the renal units and leads on all tendering for new business.

Isaac Dossa Chief Financial Officer
 

Isaac has extensive experience in the renal industry, having spent several years as UK Finance Director for a Global Healthcare Company under private equity ownership where he oversaw significant profitable growth. Isaac has in all previous roles lead businesses through transformational change and has a proven record of implementing financial and operational controls that competitively position the business.

Isaac has been recognised for his achievements which include being named Global Finance Director of the year and has twice been the recipient of Global Working Capital awards in previous roles operating in different industry sectors.

Isaac is a qualified chartered accountant and a Fellow member of CIMA. He also holds a postgraduate degree from John Moores University in Management in Change.

Manjinder Dhaliwal Financial Controller
 

Manj is responsible for financial management at Renal Services including statutory financial statements. Prior to joining Renal Services, Manj worked at the Health Professions Council (HPC) as a Financial Accountant where she was responsible for managing public funds and cash-flows together with balance sheet management.

At her time there, she was also involved with the replacement by HPC of its predecessor, the Council for Professions Supplementary to Medicine, and recently in the transfer of the General Social Care Council to HPC. Previously she worked as a Budget Accountant for Ferns Management Consulting where she was responsible for both management and financial statements. Manj is a qualified chartered accountant and an associate member of CIMA; she holds a BA (Hons) degree from the University of Kent.

Sue Woodcock Head of Nursing
 

Sue Woodcock has had a career in renal care spanning nearly 30 years. As well as her lengthy training in renal care, Sue has also obtained an MA in Medical Ethics and Law, is a Fellow of the Higher Education Academy, is an NMC Stage 4 Teacher and was Head of Nursing for a large NHS Renal unit. As Head of Nursing at Renal Services, Sue’s main focus is progressing the education and professional development opportunities for nursing staff and working with all staff and healthcare partners to focus on clinical outcomes and the quality of patient care.

The Board

Renal Services is a growing UK business and our board members are responsible for the current and future success of the company, including it’s overall strategic direction, financial management and governance.

James Buckley Non-Executive Chairman - Remuneration & Audit Committee Member

James has over fifteen years of experience working with healthcare companies. James’ focus is on companies with very significant growth potential either organically or through acquisition.
Previously he was CEO of Tunstall Healthcare, a world leading provider of
tele-healthcare solutions, growing sales to £150m from 2.5m customers in 30 countries and 1,200 staff globally. James has extensive experience of working in the UK social healthcare market and internationally.

Previously James worked for Cable & Wireless for over ten years, as well as other technology businesses.

Stefano Ciampolini Chief Executive Officer and Co-Founder
 

Stefano Ciampolini is Adjunct Professor of Imperial College Business School in London and Entrepreneur-in-Residence at Imperial’s Enterprise Lab. Stefano started his career with his family’s group of companies, which included private clinics and diagnostic equipment manufacturing in Italy, France and the United States.

He joined Arthur Andersen in London in 1996, where he was a member of the healthcare corporate finance team. In 1999, Stefano founded NephroNet, a chain of independent dialysis centers in Italy, which was sold to Baxter in 2001. From 2001 to 2003 Stefano was a Managing Director of Baxter Renal Therapy Services. Since 2002 Stefano is Managing Partner at Healthcare Capital Partners (London), a private equity and corporate finance advisory boutique specialized in life sciences and healthcare ventures that he founded. As part of his activities Stefano is a founder and board member of several healthcare ventures and private equity funds in Europe and the US.

Stefano earned an MBA from Imperial College Business School in 1994 and has a degree in Economics from Kingston University, London.

Dr Patrick Carr Head of Medical Advisory Board
 

Dr Carr graduated in medicine from King’s College London in 1981 and has been a consultant nephrologist since 1993. He is a Specialty Advisor to the Royal College of Physicians in London responsible for College approval of all consultants.

Dr Carr Chairs the Specialist Training Committee for the South Thames Region and is responsible for all postgraduate training in Nephrology. He is Senior Renal Physician and Clinical Lead Board Member at Worthing & Southlands NHS Trust and Consultant Nephrologist to Brighton Healthcare Trust.

Over the past 20 years Dr Carr has held a number of managerial and clinical positions inside the NHS and published several articles in European medical journals.

Scott Maguire Director and Co-Founder - Remuneration Committee Member

Scott, co-founder of Renal Services, started his career in banking with Merrill Lynch in New York in 1987. Formerly Scott was a senior manager in global corporate development at National Medical Care (NMC, now Fresenius Medical Care), at the time the world’s largest Haemdialysis provider. During his tenure at NMC he assisted in building the international division and completed over 100 haemodialysis clinic transactions.

He played a key role in building NMCs leading UK and European presence. Since 2002 Scott has been a partner at Healthcare Capital Partners, a company that he founded with Stefano Ciampolini. He is currently CEO of Xenetic Biosciences Inc (ticker: XBIO), a biotechnology company listed on NASDAQ and a company he originally listed on AIM (known as Lipoxen) in 2006 and has since moved to the operations as well as the listing to the US. Prior to XBIO and HCP, Scott was a director (1996-2001) of Arthur Andersen’s Healthcare Corporate Finance, a practice he co-founded in 1996 which he helped build to 32 corporate financiers across the US and Europe. He was also lead advisor to Total Renal Care (now DaVita) on their European business development initiatives (1997-1999).

Scott studied biochemistry as an undergraduate and completed an MBA.

George Tsangarides Remuneration & Audit Committee Member
 

George was appointed to the board at Renal Services as part of the investment from BGF. He sits on the remuneration and audit committees.

George joined BGF in early 2012 and is based in the London office. Covering London, Essex and Norfolk, George is responsible for identifying and completing new investment opportunities as well as continuing to work with the boards of BGF’s investee companies.
Prior to BGF, George advised a number of large cap companies in fundraising and M&A across the Telecoms, Media and Technology sectors as an investment banker at Bank of America Merrill Lynch.
He holds a MA Oxon in Politics, Philosophy and Economics from Oxford University and a MSc in Finance from the London School of Economics.

Henrik Westling Director - Audit Committee Member
 

Henrik graduated from Delta State University, Mississippi and Linkoping University in Sweden with BAs in Finance, Accounting and Management Control. Henrik started his professional career at Arthur Andersen in 1994, where he mainly worked in the Corporate Finance practice in London and in Stockholm. In 2002, he joined Evli Bank in Stockholm following its acquisition of Arthur Andersen’s Nordic Corporate Finance operations. Since then he has been responsible for Evli’s Healthcare Corporate Finance team with focus on healthcare M&A in Northern Europe. Henrik has project led a significant number of domestic and cross-border transactions in the healthcare industry, including several dialysis related transactions.

Yiannos Mouzouris Director
 

Yiannos graduated with a PhD in electrical engineering and MS in finance, investment and banking from the University of Wisconsin-Madison in 1998.

After graduation he worked for Prudential Securities Inc. in New York where he was responsible for structuring asset-backed securities, and subsequently for Tufton Oceanic in Cyprus and Dubai where he was responsible for developing fund management products and working on corporate finance transactions in the maritime sector.

He joined the Interorient Group, Cyprus, in 2005 where he is responsible for business development. He has been actively involved in several acquisitions and joint venture investments and has served on the boards of public and private companies.

Inspired Patient Care

Founded in 2007, Renal Services operates eleven dialysis units across the UK. We aim to improve patients’ quality of life, allowing them easier access to local haemodialysis and more personal freedom.

Investors

In November 2014, Renal Services received an investment of £3.1m in growth capital from BGF (Business Growth Fund). The funding is allowing Renal Services to expand its network of dialysis centres across the UK and open new units.
Alongside its equity investment, BGF contributed additional support to the company through the introduction of James Buckley as Non-Executive Chairman. James has an extensive background in the healthcare sector, formerly as CEO of Tunstall Group until 2009 and currently as Chairman of Ark Home Healthcare and Mangar International, and Non-Executive Director of Prism Medical.